References
- Aljaeid BM, Hosny KM. 2016. Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity. Int J Nanomedicine. 11:441–447.
- Almeidaa H, Lobãoa P, Frigeriobc C, Fonseca J, Silva R, Sousa Lobo JM, Amaral MH. 2017. Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen. Pharm Dev Technol. 22:336–349.
- Araujo L, Sheppard M, Löbenberg R, Kreuter J. 1999. Uptake of PMMA nanoparticles from the gastrointestinal tract after oral administration to rats: modification of the body distribution after suspension in surfactant solutions and in oil vehicles. Int J Pharm. 176:209–224.
- Berkner KL, Runge KW. 2004. The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis. J Thromb Haemost. 2:2118–2132.
- Conly JM, Stein K. 1992. Quantitative and qualitative measurements of K vitamins in human intestinal contents. Am J Gastroenterol. 87:311–316.
- Davidson KW, Sadowski JA. 1997. Determination of vitamin K compounds in plasma or serum by high-performance liquid chromatography using postcolumn chemical reduction and fluorimetric detection. Meth Enzymol. 282:408–421.
- Ekambaram P, Sathali AAH, Priyanka K. 2012. Solid lipid nanoparticles: a review. Sci Rev Chem Commun. 2:80–102.
- Elshafeey A, Bendas E, Mohamed O. 2009. Intranasal microemulsion of sildenafil citrate: in vitro evaluation and in vivo pharmacokinetic study in rabbits. AAPS PharmSciTech. 10:361–367.
- Han Y, Li Y, Zhang P, Sun J, Li X, Sun X, Kong F. 2016. Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy. Pharm Dev Technol. 21:277–281.
- Hosny KM, Ali SM. 2012. Novel controlled release oxypentifylline microspheres: preparation, characterization and in-vivo evaluation. Afr J Pharm Pharmacol. 6:2039–2048.
- Hosny KM, Aljaeid BM. 2014. Sildenafil citrate as oral solid lipid nanoparticles: a novel formula with higher bioavailability and sustained action for treatment of erectile dysfunction. Expert Opin Drug Deliv. 11:1015–1022.
- Hosny KM, Banjar ZM. 2013. The formulation of a nasal nanoemulsion zaleplon in situ gel for the treatment of insomnia. Expert Opin Drug Deliv. 10:1033–1041.
- Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C, Mader K. 2004. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release. 95:217–227.
- Liu Z, Zhang X, Wu H, Li J, Shu L, Liu R, Li L, Li N. 2011. Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo. Drug Dev Ind Pharm. 37:475–481.
- Monteiro LM, Lione VF, do Carmo FA, da Silva JH, Nasciutti LE, Rodrigues CR, Castro HC, de Sousa VP, Cabral LM. 2012. Development and characterization of a new oral dapsone nanoemulsion system: permeability and in silico bioavailability studies. Int J Nanomedicine. 7:5175–5182.
- Müller RH, Radtke M, Wissing SA. 2002. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 1:131–155.
- Pardeike J, Hommoss A, Müller RH. 2009. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 366:170–184.
- Park BK, Scott AK, Wilson AC, Haynes BP, Breckenridge AM. 1984. Plasma disposition of vitamin K1 in relation to anticoagulant poisoning. Br J Clin Pharmacol. 18:655–662.
- Ruenraroengsak P, Cook JM, Florence AT. 2010. Nanosystem drug targeting: facing up to complex realities. J Control Release. 141:265–276.
- Sharma P, Ganta S, Denny WA, Garg S. 2009. Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: chlorambucil. Int J Pharm. 367:187–194.
- Shearer MJ, Newman P. 2008. Metabolism and cell biology of vitamin K. Thromb Haemost. 100:530–547.
- Shearer MJ. 1997. The roles of vitamins D and K in bone health and osteoporosis prevention. Proc Nutr Soc. 56:915–937.
- Zhang Y, Huo M, Zhou J, Xie S. 2010. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Prog Biomed. 99:306–314.